These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15232685)

  • 1. Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy.
    Adhikary L; Chow F; Nikolic-Paterson DJ; Stambe C; Dowling J; Atkins RC; Tesch GH
    Diabetologia; 2004 Jul; 47(7):1210-1222. PubMed ID: 15232685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice.
    Lim AK; Nikolic-Paterson DJ; Ma FY; Ozols E; Thomas MC; Flavell RA; Davis RJ; Tesch GH
    Diabetologia; 2009 Feb; 52(2):347-58. PubMed ID: 19066844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 MAPK activity is associated with the histological degree of interstitial fibrosis in IgA nephropathy patients.
    Lee J; An JN; Hwang JH; Lee H; Lee JP; Kim SG
    PLoS One; 2019; 14(3):e0213981. PubMed ID: 30897126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats.
    Wang J; Huang H; Liu P; Tang F; Qin J; Huang W; Chen F; Guo F; Liu W; Yang B
    Eur J Pharmacol; 2006 Dec; 553(1-3):297-303. PubMed ID: 17074319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal p38 MAP kinase activity in experimental diabetes.
    Komers R; Lindsley JN; Oyama TT; Cohen DM; Anderson S
    Lab Invest; 2007 Jun; 87(6):548-58. PubMed ID: 17401436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
    Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
    Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
    Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
    Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Down-regulation of p38 MAPK and collagen by 1, 25-(OH)2-VD3 in rat models of diabetic nephropathy].
    Xie X; Li Z; Pi M; Wu J; Zeng W; Zuo L; Zha Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):931-5. PubMed ID: 27363275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy.
    Rane MJ; Song Y; Jin S; Barati MT; Wu R; Kausar H; Tan Y; Wang Y; Zhou G; Klein JB; Li X; Cai L
    Am J Physiol Renal Physiol; 2010 Jan; 298(1):F49-61. PubMed ID: 19726550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
    Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
    Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced beta 2 glycoprotein I improves diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathway.
    Wang T; Chen SS; Chen R; Yu DM; Yu P
    Int J Clin Exp Pathol; 2015; 8(3):2321-33. PubMed ID: 26045739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP7 reduces inflammation and oxidative stress in diabetic tubulopathy.
    Li RX; Yiu WH; Wu HJ; Wong DW; Chan LY; Lin M; Leung JC; Lai KN; Tang SC
    Clin Sci (Lond); 2015 Feb; 128(4):269-80. PubMed ID: 25200314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of lovastatin on renal function and expression of phosphorylating-p38 mitogen-activated protein kinase in experimental diabetic nephropathy in rats].
    Wang LH; Duan HJ; Shi YH; Liu QJ; He N; Liu SX
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):734-7. PubMed ID: 15585148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes.
    Purvis GSD; Chiazza F; Chen J; Azevedo-Loiola R; Martin L; Kusters DHM; Reutelingsperger C; Fountoulakis N; Gnudi L; Yaqoob MM; Collino M; Thiemermann C; Solito E
    Diabetologia; 2018 Feb; 61(2):482-495. PubMed ID: 29085990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes.
    Kang SW; Natarajan R; Shahed A; Nast CC; LaPage J; Mundel P; Kashtan C; Adler SG
    J Am Soc Nephrol; 2003 Dec; 14(12):3178-87. PubMed ID: 14638916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallic acid ameliorates renal functions by inhibiting the activation of p38 MAPK in experimentally induced type 2 diabetic rats and cultured rat proximal tubular epithelial cells.
    Ahad A; Ahsan H; Mujeeb M; Siddiqui WA
    Chem Biol Interact; 2015 Oct; 240():292-303. PubMed ID: 26341651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy.
    Wei TT; Yang LT; Guo F; Tao SB; Cheng L; Huang RS; Ma L; Fu P
    Acta Pharmacol Sin; 2021 Feb; 42(2):252-263. PubMed ID: 32948825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
    Song W; Wei L; Du Y; Wang Y; Jiang S
    Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy.
    Tikoo K; Meena RL; Kabra DG; Gaikwad AB
    Br J Pharmacol; 2008 Mar; 153(6):1225-31. PubMed ID: 18204486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus.
    Westermann D; Rutschow S; Van Linthout S; Linderer A; Bücker-Gärtner C; Sobirey M; Riad A; Pauschinger M; Schultheiss HP; Tschöpe C
    Diabetologia; 2006 Oct; 49(10):2507-13. PubMed ID: 16937126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.